Valkyrie Pharmaceutical Susta 300 is presented in a 10-milliliter multidose vial and reportedly contains 300 milligrams of a blend of four testosterone esters per milliliter according to label and/or packaging. Samples of this product were purchased from a European-based internet source between the dates of January 1, 2018 and February 28, 2018.
The samples were forwarded and received by the analytical laboratory SIMEC AG on February 28, 2018. SIMEC performed HPLC-UV quantitative dosage testing, ‘total aerobial microbiological count’ (TAMC) testing and ‘total yeast and mold count’ (TYMC) testing on March 9, 2018. The report was completed on March 27, 2018.
The product was identified with batch number “HGM2049” and an expiration date of November 2019.
Label claim: Valkyrie Pharma Susta 300 has a label claim of 36 mg/ml testosterone propionate, 72 mg/ml testosterone phenylpropionate, 72 mg/ml testosterone isocaproate and 120 mg/ml testosterone decanoate.
Actual content: Valkyrie Pharma Susta 300 was determined to have an actual content of 27.5 mg/ml testosterone propionate, 47.2 mg/ml testosterone phenylpropionate, 57.9 mg/ml testosterone isocaproate and 81.0 mg/ml testosterone decanoate.
No microbiological contamination was detected.
(The following images are photographs of the actual product that was submitted for testing.)
Does Valkyrie Pharmaceutical Susta 300 contain 36 mg testosterone propionate, 72 mg testosterone phenylpropionate, 72 mg testosterone isocaproate and 120 mg testosterone decanoate in each milliliter of...
|Last Updated||April 15, 2019|